A best evidence topic was written according to a structured protocol. The question addressed was whether smoking cessation prior to cardiac surgery would result in a greater freedom from postoperative complications. A total of 564 papers were found using the reported searches, of which five represented the best evidence to answer the clinical question. The authors, date, journal, study type, population, main outcome measures and results are tabulated. Reported measures were operative mortality, pulmonary complications, infective complications, neurological complications, transfusion requirements, duration of ventilation, intensive care unit and hospital stay, intensive care unit re-admission, postoperative gas exchange parameters and postoperative pulmonary function. The largest of the best evidence studies demonstrated a significant reduction in pulmonary complications in non-smokers (P < 0.001); however, there was an increased requirement for transfusion in this cohort (P = 0.002). There were non-significant reductions in neurological complications, infective complications and re-admissions to intensive care. Another large cohort study demonstrated significant reductions in non-smokers in mortality (P < 0.0001), pulmonary complications (P = 0.0002), infection (P < 0.0007), intensive care unit re-admission (P = 0.0002), duration of mechanical ventilation (P = 0.026) and intensive care unit stay (P = 0.002). A larger cohort study again demonstrated significant reductions in non-smokers in pulmonary complications (P < 0.002), duration of mechanical ventilation (P < 0.012) and intensive care unit stay (P < 0.005). A smaller prospective cohort study reported significantly raised PaO 2 (P = 0.0091) and reduced PaCO 2 (P < 0.0001) levels in the non-smokers as well as improved FVC and FEV 1 (P < 0.0001). There were also reductions in duration of intubation (P < 0.0001), intensive care unit stay (P < 0.0001) and hospital stay (P < 0.0013). Another small cohort study reporting outcomes of heart transplantation demonstrated significant improvement in non-smokers in terms of survival (P = 0.031), duration of intubation (P = 0.05) and intensive care unit stay (P = 0.021). We conclude that there is strong evidence demonstrating superior outcomes in non-smokers following cardiac surgery and advocate the necessity of smoking cessation as soon as possible prior to cardiac surgery.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in ICVTS [1] .
CLINICAL SCENARIO
An asymptomatic 67-year-old man with a significant threevessel disease on coronary angiography is referred for consideration of a coronary artery bypass surgery (CABG). He has been a life-long smoker with a 20-pack-year smoking history. However, his pulmonary function tests are within acceptable limits. He has no other respiratory comorbidities. You advise him regarding smoking cessation and consider whether to delay his operation until he has quit smoking. Pulmonary complication Current smokers: 60 (11.0%) Never smokers: 37 (6.8%) P = 0.01
THREE-PART QUESTION
Patients stratified into two groups: Current smokers (n = 554) Never smokers (n = 554) ICU re-admission Current smokers: 38 (6.9%) Never smokers: 22 (4.0%) P = 0.03
The two groups were sub-stratified Current smokers: ≤70 years (n = 473) >70 years (n = 81) Never smokers: 
Continued

SEARCH OUTCOME
Five hundred and sixty-four articles were found using the reported search strategy. From these, five articles were identified that provided the best evidence to answer the question. These are presented in Table 1 .
RESULTS
Al-Sarraf et al. [2] conducted a retrospective cohort study of 2587 consecutive patients undergoing isolated CABG. The patients were stratified into three groups of current smokers (n = 473); former smokers, having stopped >4 weeks pre operatively (n = 1346); and non-smokers (n = 748). Significant reductions in pulmonary complications were observed between the groups, with incidences of 30.1, 23.3 and 19.9% in the current smokers, former smokers and non-smokers, respectively (P < 0.001). An inverse relationship in blood transfusion requirements was observed, with incidences of 34.9, 37.5 and 44.1% in the current smokers, former smokers and non-smokers, respectively (P = 0.002). Statistically non-significant reductions were observed in neurological complications (7.2, 6.1 and 5.2%, respectively, P = 0.377), infective complications (9.5, 8.9 and 7.6%, respectively, P = 0.459) and re-admissions to the intensive care unit (4.0, 3.2 and 2.1%, respectively, P = 0.163). Jones et al. [3] conducted a retrospective cohort study of 1108 patients undergoing cardiac surgery, stratified into two groups, current smokers (n = 554) and never smokers (n = 554). A further subgroup analysis was carried out on patients above and below 70 years of age. There was a non-significant reduction in operative mortality in the never smokers (2.3 vs 4.3%, P = 0.067). There were significant reductions in the never smokers in terms of pulmonary complications (6.8 vs 11%, P = 0.01), intensive care unit readmission (4.0 vs 6.9%, P = 0.03) and infection (22.0 vs 31.8%, P < 0.001). In the subgroup analysis of the >70-year old patients, there were significant reductions in the never smokers in terms of operative mortality (2.1 vs 14.8%, P < 0.0001), pulmonary complications (8.2 vs 24.7%, P = 0.0002), intensive care unit re-admission (5.2 vs 19.8%, P = 0.0002), infection (23.8 vs 44.4%, P < 0.0007), new renal replacement (3.1 vs 17.3%, P < 0.0001), mean mechanical ventilation hours (37.5 vs 76.1, P = 0.026) and mean intensive care unit days (2.8 vs 6.2, P = 0.002).
Ngaage et al. [4] conducted a retrospective cohort study of 2163 patients undergoing elective cardiac surgery, stratified into three groups: smokers (n = 207), ex-smokers (n = 1075) and non-smokers (n = 881). Significant reductions in favour of the non-smoking groups were observed in terms of mean intensive care unit hours (60, 34 and 31 in the smokers, ex-smokers and non-smokers, respectively, P < 0.005), pulmonary complications (29.5, 14.7 and 13.6%, respectively, P < 0.002) and mean mechanical ventilation hours (16, 7.9 and 8.3, respectively, P < 0.012).
Arabaci et al. [5] conducted a prospective cohort study of 213 consecutive patients undergoing elective isolated CABG. Patients were stratified into two groups: smokers (n = 117) and nonsmokers, having stopped >20 years preoperatively (n = 96).
Postoperative arterial blood gas analysis demonstrated significantly superior results for the non-smokers in PaO 2 (mmHg) (69.1 vs 66.1, P = 0.0091) and PaCO 2 (mmHg) (32.0 vs 38.6, P < 0.0001). Postoperative pulmonary function tests demonstrated significant increases in the non-smokers in vital capacity (VC, L) (2.7 vs 2.3, P < 0.0001), forced vital capacity (FVC, L) (2.8 vs 2.4, P < 0.0001), forced expiratory volume (FEV 1 , L) (2.1 vs 1.7, P < 0.0001) and FEV 1 /FVC ratio (76.0 vs 72.2, P = 0.0110). There were also significant reductions in intubation hours (14.1 vs 19.9, P < 0.0001), intensive care unit days (2.4 vs 3.2, P < 0.0001) and hospitalization days (12.5 vs 14.1, P < 0.0013) in favour of the non-smokers. Sanchez-Lazaro et al. [6] conducted a retrospective cohort study of 288 patients undergoing heart transplantation, who were stratified into three groups: smokers (n = 49), ex-smokers, having stopped <1 year preoperatively (n = 76), and nonsmokers, having stopped >1 year preoperatively (n = 163). Significant improvement in survival was observed in the non-smoking groups with the rates of 81.63, 92.11 and 89.57% in the smokers, ex-smokers and non-smokers, respectively (P = 0.031). Similar improvements were observed in terms of mean intubation hours (14.2, 33.4 and 17.9, respectively, P = 0.05) and mean intensive care unit days (4.4, 7.9 and 4.84, respectively, P = 0.021).
CLINICAL BOTTOM LINE
There is convincing evidence presented that patients who are not active smokers at the time of cardiac surgery have improved outcomes postoperatively in comparison with smokers. This is evident in terms of a reduction in mortality, pulmonary complications, infective complications, duration of mechanical ventilation, intensive care unit stay and re-admission and overall hospital stay. There are also improvements observed in post operative gas exchange and pulmonary function. There is a great variation observed in the duration of smoking cessation required to achieve these outcomes; however, it is widely accepted that the longer the duration preoperatively, the greater the benefit to the patient. These findings support the necessity of smoking cessation as soon as possible prior to cardiac surgery.
